vimarsana.com

Page 42 - தேசிய ஆரோக்கியம் ஒழுங்குமுறை அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sputnik V authorized in the Kingdom of Bahrain

Sputnik V authorized in the Kingdom of BahrainMoscow, February 10, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by the National Health Regulatory Authority (NHRA) of the Kingdom of Bahrain.The.

Bahrain approves emergency use of Sputnik vaccine

Bahrain approves emergency use of Sputnik vaccine MANAMA, February 10, 2021 Bahrain today approved the emergency use of the Sputnik V vaccine, produced by the Jamalaya National Center for Epidemiological and Microbiology Research of the Ministry of Health of Russia.   The decision to authorise the Sputnik V vaccine was based on data provided by the manufacturing company, results of an expanded study, and a process of review and evaluation of effectiveness of data conducted by the Kingdom’s National Health Regulatory Authority (NHRA), said a Bahrain News Agency report.   The NHRA also reviewed and evaluated the safety of the vaccine, demonstrated by clinical trials and studies, as well as verified the quality of the vaccine by reviewing scientific data showing the quality of manufacturing and the stability of the product.

Bahrain authorizes emergency use of Sputnik V vaccine | THE DAILY TRIBUNE

The Daily Tribune – www.newsofbahrain.com The Kingdom of Bahrain today approved the emergency use of the Sputnik V vaccine, produced by the Jamalaya National Center for Epidemiological and Microbiology Research of the Ministry of Health of the Russian Federation. The decision to authorize the Sputnik V vaccine was based on data provided by the manufacturing company, results of an expanded study, and a process of review and evaluation of the effectiveness of data conducted by the Kingdom’s National Health Regulatory Authority (NHRA). The NHRA also reviewed and evaluated the safety of the vaccine, demonstrated by clinical trials and studies, as well as verify the quality of the vaccine by reviewing scientific data showing the quality of manufacturing and the stability of the product.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.